AIM ImmunoTech Inc.

12/09/2021 | Press release | Distributed by Public on 12/09/2021 06:38

Safety, tolerability and biological activity of repeated intranasal administration of Ampligen as potential antiviral treatment in healthy subjects - preliminary results